Runner Aregawi joins Sharapova in testing for meldonium

Image
AFP Stockholm
Last Updated : Mar 10 2016 | 11:42 AM IST
Swedish runner Abeba Aregawi became the latest athlete to test positive for meldonium, the same substance that tennis star Maria Sharapova was caught taking.
Five-time major champion Sharapova said the change in WADA's banned list for 2016 led to an inadvertent violation, for which she will be "provisionally suspended."
Sharapova said she had been taking meldonium for ten years for health reasons.
The founder of meldonium suggested that the drug would not help boost performance.
Former world champion Aregawi joins an ever-growing list of sportspeople to have tested positive for the drug this year, others include the 2015 Tokyo marathon champion Endeshaw Negesse, Ukrainian biathletes Olga Abramova and Artem Tyschcenko, as well as Russian ice dancer Ekaterina Bobrova.
Ethiopian-born Aregawi had already failed an initial doping test two weeks ago.
"Two samples were taken, an A and a B sample. The A sample had already come back positive, and is usually the case when that happens, the B sample has now also come back positive," said Tommy Forsgren, the doping manager for the Swedish Athletic Association.
"Unfortunately, we're not surprised."
Aregawi, a 1500m specialist, now risks a suspension of up to four years.
She assumed responsibility for the doping on Wednesday.
"I previously received pills from a doctor in Ethiopia. I thought they were vitamins. It's my own fault that I took these pills without checking," Arewagi said in a statement released by the Swedish Athletic Association.
The 25-year-old, who competed for Ethiopia at the London 2012 Olympics, was world champion in 2013 in Moscow, but finished only sixth in Beijing last year.
She also won the European Championships and the World Indoors titles over her favourite distance.
Aregawi switched allegiances to Sweden soon after the Olympics, through her marriage to a naturalised Swede of Ethiopian origin, of which she was accused of doing just to gain citizenship.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 10 2016 | 11:42 AM IST

Next Story